ICON Public Limited Company (ICLR)

Market Cap	12.23B
Revenue (ttm)	8.10B
Net Income (ttm)	599.48M
Shares Out	76.36M
EPS (ttm)	7.47
PE Ratio	21.70
Forward PE	12.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	97,739
Open	160.91
Previous Close	162.18
Day's Range	159.42 - 162.38
52-Week Range	125.10 - 228.29
Beta	1.26
Analysts	Buy
Price Target	205.07 (+28.03%)
Earnings Date	Oct 22, 2025

About ICLR

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: May 15, 1998
• Employees: 41,900
• Stock Exchange: NASDAQ
• Ticker Symbol: ICLR
• Website: https://www.iconplc.com

Financial Performance

In 2024, ICLR's revenue was $8.28 billion, an increase of 1.99% compared to the previous year's $8.12 billion. Earnings were $791.47 million, an increase of 29.26%.

Analyst Summary

According to 15 analysts, the average rating for ICLR stock is "Buy." The 12-month stock price target is $205.07, which is an increase of 28.03% from the latest price.

Price Target

$205.07

(28.03% upside)

Analyst Consensus: Buy